Candel Therapeutics, Inc. · NASDAQ:CADL
Paul B Manning reported a 7.90% stake in Candel Therapeutics, Inc. (Schedule 13D/A)
Event Dec 16, 2024 · Filed Mar 18, 2026
Paul B Manning reported a 7.90% stake in Candel Therapeutics, Inc., 5,790,999 shares, with active intent on Dec 16, 2024. Filed Mar 18, 2026 (Schedule 13D/A).
- Stake
- 7.90%
- Shares
- 5,790,999
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paul B Manning | 7.90% | 5,790,999 |
| The Paul B. Manning Revocable Trust dated May 10, 2000 | 3.80% | 2,763,527 |
| BKB Growth Investments, LLC | 1.80% | 1,303,752 |